Early decrease in intermediate monocytes in peripheral blood is characteristic of multiple system atrophy-cerebellar type

J Neuroimmunol. 2020 Dec 15:349:577395. doi: 10.1016/j.jneuroim.2020.577395. Epub 2020 Sep 20.

Abstract

To identify biomarkers for multiple system atrophy-cerebellar type (MSA-C), we used flow cytometry to measure surface marker expression of peripheral blood monocytes from patients with MSA-C or hereditary spinocerebellar degeneration (hSCD) and from healthy controls (HCs). The percentage of intermediate monocytes was significantly lower in MSA-C patients than in hSCD patients and HCs and showed significant positive correlations with disease duration and unified MSA rating scale scores. The percentage of CD62L+ intermediate monocytes was significantly lower in MSA-C patients than in hSCD patients and HCs. Early decrease of peripheral blood intermediate monocytes is characteristic of MSA-C and is a biomarker.

Keywords: Biomarker; Intermediate monocyte; Monocyte; Multiple system atrophy; Surface marker.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cerebellum / metabolism*
  • Cerebellum / pathology*
  • Female
  • Humans
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Middle Aged
  • Monocytes / metabolism*
  • Multiple System Atrophy / blood*
  • Multiple System Atrophy / diagnosis*
  • Olivopontocerebellar Atrophies / blood
  • Olivopontocerebellar Atrophies / diagnosis